Estimated read time: 1-2 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
(AP) - A look at health care giant Johnson & Johnson's third-quarter revenue by division and for selected products and categories:
CONSUMER HEALTH PRODUCTS 3Q 2013 3Q 2012 Change
U.S. Total $1.23 B $1.21 B up 0.9 percent
International Total $2.39 B $2.37 B up 0.8 percent
Worldwide Total $3.61 B $3.58 B up 0.8 percent
Nonprescription drugs/nutritionals-U.S. $310 M $263 M up 17.9 percent
PRESCRIPTION DRUGS 3Q 2013 3Q 2012 Change
U.S. Total $3.55 B $3.29 B up 7.9 percent
International Total $3.49 B $3.11 B up 12 percent
Worldwide Total $7.04 B $6.40 B up 9.9 percent
Remicade (immune disorders) $1.69 B $1.59 B up 6.2 percent
Stelara (psoriasis) $370 M $287 M up 29 percent
Prezista (HIV) $410 M $364 M up 12.6 percent
Concerta (attention deficit disorder) $142 M $254 M down 44 percent
Invega Sustenna (schizophrenia) $324 M $212 M up 53 percent
Zytiga (prostate cancer) $464 M $265 M up 75 percent
Velcade (multiple myeloma) $404 M $327 M up 24 percent
Procrit (anemia from cancer/dialysis) $344 M $359 M down 4.2 percent
Xarelto (clot prevention) $246 M $68 M up 262 percent
MEDICAL DEVICES & DIAGNOSTICS 3Q 2013 3Q 2012 Change
U.S. Total $3.15 B $3.29 B down 4.2 percent
International Total $3.78 B $3.78 B down 0.1 percent
Worldwide Total $6.93 B $7.07 B down 2 percent
Diabetes Care-U.S. $237 M $328 M down 28 percent
Diagnostic Tests/Equipment-Global $459 M $513 M down 10.5 percent
Orthopedic Products-Global $2.28 B $2.29 B down 0.3 percent
TOTAL SALES 3Q 2013 3Q 2012 Change
U.S. $7.93 B $7.79 B up 1.7 percent
International $9.65 B $9.26 B up 4.2 percent
Worldwide Total $17.58 B $17.05 B up 3.1 percent
___
Source: Johnson & Johnson
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
